Clinical trials: Moderate to Severe Midface Volume Deficit
Moderate to Severe Midface Volume Deficit
Evaluation of the Merz Cheek Fullness Assessment Scale in the Treatment of Midface Volume Deficit
Evaluation of the sensitivity of the Merz Cheeks Fullness Assessment Scale (MCFAS) and the clinical relevance of aesthetically pleasing outcomes by detecting changes in cheek appearance after Belotero® Volume Lidocaine injection.
- Trial name
- NCT03321825
- Testing
- Belotero® Volume Lidocaine
- Where
- 3 sites in Canada
- Volunteers
- 66 people
- Sponsor
- Merz North America, Inc.
Moderate to Severe Midface Volume Deficit
Saypha® VOLUME Lidocaine for Midface Augmentation
The clinical investigation is a randomized, subject- and evaluator-blinded, active treatment controlled, multicenter, clinical investigation, to demonstrate the non inferiority of saypha® VOLUME Lidocaine to one of the devices…
- Trial name
- VOLIDO (NCT05386030)
- Testing
- saypha® VOLUME Lidocaine, Juvéderm® Voluma™ XC
- Where
- 16 sites in United States
- Volunteers
- 562 people, healthy volunteers welcome
- Sponsor
- Croma-Pharma GmbH